OriGene Technologies Raises $16M | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – OriGene Technologies has raised $16 million in a Series B financing led by IDG-Accel, SBI & TH Venture Capital Enterprise, and Zero2IPO, the firm said yesterday.

The Rockville, Md.-based genetic tools company said that previous investors Morningside Venture Investments and President International Development also participated in the round.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genomic analysis of 200 bird species, and more.

The Australian High Court rules that isolated genetic material cannot be patented.

The startup incubator Y Combinator is launching a nonprofit research lab.

In Genome Research this week: vervet genome, tandem repeats affect gene expression in great apes, and more.